 91 citations
,
  May 2005   in “The Journal of Clinical Endocrinology & Metabolism”
           91 citations
,
  May 2005   in “The Journal of Clinical Endocrinology & Metabolism”    A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.  
      62 citations
,
  August 2014   in “BMC Endocrine Disorders”
           62 citations
,
  August 2014   in “BMC Endocrine Disorders”    New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.  
      54 citations
,
  December 2007   in “Best Practice & Research Clinical Endocrinology & Metabolism”
           54 citations
,
  December 2007   in “Best Practice & Research Clinical Endocrinology & Metabolism”    Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.  
      51 citations
,
  June 2021   in “Signal Transduction and Targeted Therapy”
           51 citations
,
  June 2021   in “Signal Transduction and Targeted Therapy”    The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.  
      43 citations
,
  August 2010   in “Expert Opinion on Investigational Drugs”
           43 citations
,
  August 2010   in “Expert Opinion on Investigational Drugs”    Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.